Essential oils from fresh leaves of Eucalyptus urophylla (EOEU) and E. brassiana (EOEB), obtained by hydrodistillation, were orally administered to Swiss male mice 60 min before experimental procedures. EOEU and EOEB at either 200 or 400 mg/kg were evaluated for sedative/hypnotic activity through pentobarbital sleeping time, locomotor activity by open-field procedure, and anticonvulsant activity through seizures induced by pentylenetetrazole. EOEU and EOEB were effective in increasing the sleeping time, as well as diminishing ambulation in the open-field test. In addition, EOEU (but not EOEB) significantly increased the number of mice protected against PTZ-induced death. Our results are in accord with the ethnopharmacological use of Eucalyptus species, and, after complementary toxicological studies, could support further investigations to assess their use as sedative agents.
From Eucalyptus leaf essential oils several monoterpenes have been isolated, with cineole, the major constituent of the medicinal oils [2] , although many other constituents have also been reported, such as phellandrene and p-cymene [3, 4] . Cineole was demonstrated to have a significant inhibitory effect on locomotion and also potentiated the pentobarbital sleeping time in mice, indicating a plausible depressant effect on the central nervous system [5] .
Although Eucalyptus essential oils are employed to treat various medical conditions, so far no published reports have appeared on the pharmacological activity of E. urophylla and E. brassiana. In an attempt to establish the central nervous system effect of the essential oils of these two Eucalyptus essential oils, the present study verifies the possible sedative effects of these oils in mice.
EOEU at a dose of 400 mg/kg exhibited protection against death (50%; p<0.05), but did not alter the onset time of seizure compared with the control group (Table 1) . Furthermore, DZP prolonged the seizure latency and prevented any deaths, whereas there was 100% mortality in the control group.
EOEU at a dose of 400 mg/kg and EOEB at both doses significantly (*p<0.05) decreased the number of squares crossed. DZP decreased all the parameter compared with the controls. In the sleeping time test, EOEU at both doses potentiated pentobarbital sleeping time (Table 2) .
In this work, the effects of essential oils from E. urophylla and E. brassiana leaves were studied in animal models of behavior, such as PTZ-induced seizures, and open-field and PTB-induced sleeping tests. These are classical models for screening central nervous system actions providing information about anticonvulsant, psychomotor performance and sedative activities. The essential oils showed a depressant effect on the central nervous system.
Decrease in sleeping latency and increase in sleeping time induced by pentobarbital, as observed after treatment with EOEU and EOEB, are conventional measures related to a sedative/hypnotic property. Nevertheless, it is a non-specific test, since compounds that decrease the rate of hepatic biotransformation of barbiturates can show the same behavioral effects as central nervous system depressant drugs [6] The main compounds in EOEU and EOEB, cineole and phellandrene [7] , were recognized as enzyme inducers, suggesting central depressant activity instead of nonspecific action upon barbiturate metabolism.
The anticonvulsant property was evaluated by an experimental procedure widely used to investigate antiepileptic drugs, with high predictive value for detection of clinically effective drugs [8] . None of the essential oils evaluated were effective in protecting mice against clonic seizures induced by PTZ; however, EOEU was able to modify the progress of mortality induced by PTZ. The PTZ test identifies drugs with efficacy against non-convulsive absence and myoclonic seizures, acting due to an increase of the seizure threshold. The lack of effect on PTZ-induced seizures suggests that EOEU and EOEB might have no effect on GABAergic neurotransmission. Since isolated cineole was able to protect mice against convulsive episodes and to show anxiolytic activity [9] , the results obtained with EOEU are probably due to its high amount of cineole.
The open field test allows evaluation of the autonomic effect of drugs and general animal activity [10] . The test was used to assess the locomotor and exploratory activity, and the low performance observed in mice treated with EOEU and EOEB, in relation to the control group, suggests impaired motor coordination, equilibrium and exploratory behavior due to treatment with the essential oils.
Aromatic compounds and essential oils that possess sedative effects alter mice mobility after inhalation [11] . The results were more prominent with EOEU, probably due to the high content of 1,8-cineole (80%) and the depressor effect of EOEB can be related to an interference of barbiturate metabolism.
These results reinforce the biological and cultural value of traditional studies in the search for new drugs for treatment of CNS disturbances. In conclusion, our data show that the essential oils of E. urophylla and E. brassiana leaves have CNS depressor activity in mice. The observed variation can be related, partially, to the chemical composition of the oils. This study provides more knowledge about the Eucalyptus genus, from which only E. globulus is utilized for medicinal purposes in Brazil. Nevertheless, more studies are needed in order to determine the action mechanism and toxicological profile. 
